LFA
IDXX icon

Legacy Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Legacy Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14
Closed -$3K – 477
2019
Q1 		$3K Buy
+14
New +$2.89K ﹤0.01% 855

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Legacy Financial Advisors's IDXX Position: Q2 2019 in Review

Legacy Financial Advisors sold out of Idexx Laboratories (IDXX) in Q2 2019, closing a stake of 14 shares — an estimated $3K sold.

Legacy Financial Advisors first reported a position in IDXX in Q1 2019 and held it in 1 quarter. The position peaked at $3K in Q1 2019. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.

  • Legacy Financial Advisors reported no remaining Idexx Laboratories position as of Q2 2019 after selling out during the quarter.
  • Legacy Financial Advisors sold 14 Idexx Laboratories shares in Q2 2019, an estimated $3K.
  • Legacy Financial Advisors first reported a position in Idexx Laboratories in Q1 2019 and held it in 1 quarter.
  • Legacy Financial Advisors's Idexx Laboratories position peaked at $3K in Q1 2019.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.

Based on Legacy Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.